Protective effect of resveratrol against lipopolysaccharide-induced oxidative stress in rat brain

Brain Injury

Volumn 23, Issue 13-14, 2009, Pages 1089-1094

  Sebai, Hichem ^a,b   Gadacha, Wafa ^a   Sani, Mamane ^a   Aouani, Ezzedine ^c   Ghanem Boughanmi, Néziha ^c   Ben Attia, Mossadok ^a  

^a University of Carthage   (Tunisia)

^b AIX MARSEILLE UNIVERSITY   (France)

^c CENTRE DE BIOTECHNOLOGIE DE BORJ CÉDRIA   (Tunisia)

Author keywords

Iron; Lipopolysaccharide; Neuroprotection; Nitric oxide; Oxidative stress; Resveratrol

Indexed keywords

CATALASE; IRON; LIPOPOLYSACCHARIDE; MALONALDEHYDE; NITRIC OXIDE; PEROXIDASE; RESVERATROL; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN REGION; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 70450216596     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699050903379370     Document Type: Article

References (44)

1. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Annals of Surgery 1992;216: 117-134.
2. Van Amersfoort ES, Van Berkel TJ, Kuiper J. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clinical Microbiology Reviews 2003;16: 379-414.
3. Ikeda M, Nakabayashi K, Shinkai M, Hara Y, Kizaki T, Oh-ishi S, Ohno H. Supplementation of antioxidants prevents oxidative stress during a deep saturation dive. The Tohoku Journal of Experimental Medicine 2004;203: 353-357.
4. Christen Y. Oxidative stress and Alzheimer disease. The American Journal of Clinical Nutrition 2000;71:621S-629S.
5. Saito M, Satoh S, Kojima N, Tada H, Sato M, Suzuki T, Senoo H, Habuchi T. Effects of a phenolic compound, resveratrol, on the renal function and costimulatory adhesion molecule CD86 expression in rat kidneys with ischemia/ reperfusion injury. Archives of Histology and Cytology 2005;68:41-49.
6. Hung LM, Chen JK, Huang SS, Lee RS, Su MJ. Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. Cardiovascular Research 2000;47: 549-555.
7. Dong W, Li N, Gao D, Zhen H, Zhang X, Li F. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. Journal of Vascular Surgery 2008;48: 709-714.
8. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-220.
9. Maccarrone M, Lorenzon T, Guerrieri P, Agrò AF. Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity. European Journal of Biochemistry 1999;265:27-34.
10. Juan SH, Cheng TH, Lin HC, Chu YL, Lee WS. Mechanism of concentration-dependent induction of heme oxygenase-1 by resveratrol in human aortic smooth muscle cells. Biochemical Pharmacology 2005;69:41-48.
11. Mokni M, Elkahoui S, Limam F, Amri M, Aouani E. Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochemical Research 2007;32: 981-987.
12. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods in Enzymology 1990;186:421-431.
13. Misra HP, Fridovich I. The role of superoxide anion in autoxidation of epinephrine and a simple assay for superoxide dismutase. The Journal of Biological Chemistry 1972;247: 3170-3175.
14. Aebi H. Catalase in vitro. Methods in Enzymology 1984;105: 121-126.
15. Chance B, Maehly AC. Assay of catalases and peroxidases. Methods in Enzymology 1955;2:764-817.
16. Green LC, Wagner DA, Glogowski J, Shipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [15N] nitrate in biological fluids. Analytical Biochemistry 1982;126:131-138.
17. Leardi A, Caraglia M, Selleri C, Pepe S, Pizzi C, Notaro R, Fabbrocini A, De Lorenzo S, Musicò M, Abbruzzese A, et al. Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells. British Journal of Haematology 1998;102:746-752.
18. Hartree EF. Determination of protein: A modification of the Lowry method that gives a linear photometric response. Analytical Biochemistry 1972;48:422-427.
19. Freudenberg MA, Galanos C. Bacterial lipopolysaccharides: Structure, metabolism and mechanisms of action. International Reviews of Immunology 1990;6:207-221.
20. Sewerynek E, Melchiorri D, Chen L, Reiter RJ. Melatonin reduces both basal and bacterial lipopolysaccharide-induced lipid peroxidation in vitro. Free Radical Biology & Medicine 1995;19:903-909.
21. Kheir-Eldin AA, Motawi TK, Gad MZ, Abd-ElGawad HM. Protective effect of vitamin E, beta-carotene and N-acetylcysteine from the brain oxidative stress induced in rats by lipopolysaccharide. The International Journal of Biochemistry & Cell Biology 2001;33:475-482.
22. Shiki Y, Meyrick BO, Brigham KL, Burr IM. Endotoxin increases superoxide dismutase in cultured bovine pulmonary endothelial cells. The American Journal of Physiology 1987;252:436-440.
23. Rakkola R, Matikainen S, Nyman TA. Proteome analysis of human macrophages reveals the upregulation of manganesecontaining superoxide dismutase after toll-like receptor activation. Proteomics 2007;7:378-384.
24. Vallance P, Moncada S. Role of endogenous nitric oxide in septic shock. New Horizons 1993;1:77-86.
25. Kitajima S, Tsuda M, Eshita N, Matsushima Y, Saitoh M, Momma J, Kurokawa Y. Lipopolysaccharide-associated elevation of serum and urinary nitrite/nitrate levels and hematological changes in rats. Toxicology Letters 1995;78: 135-140.
26. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anemia: Implications for the anemia of chronic disease. Blood 2002;100:3776-3781.
27. Andrews NC. Anemia of inflammation: The cytokinehepcidin link. The Journal of Clinical Investigation 2004;113:1251-1253.
28. Merle U, Fein E, Gehrke SG, Stremmel W, Kulaksiz H. The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation. Endocrinology 2007;148:2663-2668.
29. Sunil VR, Patel KJ, Nilsen-Hamilton M, Heck DE, Laskin JD, Laskin DL. Acute endotoxemia is associated with upregulation of lipocalin 24p3/Lcn2 in lung and liver. Experimental and Molecular Pathology 2007;83:177-187.
30. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. The Journal of Biological Chemistry 2001;276:7806-7810.
31. Galleano M, Simontacchi M, Puntarulo S. Nitric oxide and iron: Effect of iron overload on nitric oxide production in endotoxemia. Molecular Aspects of Medicine 2004;25: 141-154.
32. Kulaksiz H, Fein E, Redecker P, Stremmel W, Adler G, Cetin Y. Pancreatic beta-cells express hepcidin, an ironuptake regulatory peptide. The Journal of Endocrinology 2008;197:241-249.
33. Mokni M, Limam F, Elkahoui S, Amri M, Aouani E. Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia/reperfusion injury. Archives of Biochemistry and Biophysics 2007;457:1-6.
34. Sebai H, Ben-Attia M, Sani M, Aouani E, Ghanem- Boughanmi N. Protective effect of resveratrol on acute endotoxemia-induced nephrotoxicity in rat through nitric oxide independent mechanism. Free Radical Research 2008;42:913-920.
35. Sebai H, Ben-Attia M, Sani M, Aouani E, Ghanem- Boughanmi N. Protective effect of resveratrol in endotoxemia- induced acute phase response in rats. Archives of Toxicology 2009;83:335-340.
36. Kasdallah-Grissa A, Mornagui B, Aouani E, Hammami M, Gharbi N, Kamoun A, El-Fazaa S. Protective effect of resveratrol on ethanol-induced lipid peroxidation in rats. Alcohol & Alcoholism 2006;41:236-239.
37. Chander V, Tirkey N, Chopra K. Resveratrol, a polyphenolic phytoalexin protects against cyclosporine-induced nephrotoxicity through nitric oxide dependent mechanism. Toxicology 2005;210:55-64.
38. Silan C, Uzun O, Comunog?lu NU, Gokçen S, Bedirhan S, Cengiz M. Gentamicin-induced nephrotoxicity in rats ameliorated and healing effects of resveratrol. Biological & Pharmaceutical Bulletin 2007;30:79-83.
39. Bi XL, Yang JY, Dong YS, Wang JM, Cui YH, Ikeshima T, Zhao YQ, Wu CF. Resveratrol inhibits nitric oxide and TNFalpha production by lipopolysaccharide-activated microglia. International Immunopharmacology 2005;5:185-193.
40. Abd El-Gawad HM, Khalifa AE. Quercetin, coenzyme Q10, and L-canavanine as protective agents against lipid peroxidation and nitric oxide generation in endotoxin-induced shock in rat brain. Pharmacological Research 2001;43:257-263.
41. Meng XL, Yang JY, Chen GL, Zhang LJ, Wang LH, Li J, Wang JM, Wu CF. RV09, a novel resveratrol analogue, inhibits NO and TNF-alpha production by LPS-activated microglia. International Immunopharmacology 2008;8: 1074-1082.
42. Andrews NC. Disorders of iron metabolism. The New England Journal of Medicine 1999;341:1986-1995.
43. Fleming RE, Sly WS. Mechanisms of iron accumulation in hereditary hemochromatosis. Annual Review of Physiology 2002;64:663-680.
44. Wang Q, Du F, Qian ZM, Ge XH, Zhu L, Yung WH, Yang L, Ke Y. Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantia nigra in rat brain. Endocrinology 2008;149:3920-3925.